Sacrosidase
Sacrosidase is a liquid enzyme replacement therapy containing recombinant yeast sacrosidase (sucrase), used to treat congenital sucrase-isomaltase deficiency (CSID), a rare genetic disorder. It hydrolyzes dietary sucrose into fructose and glucose in the small intestinal brush border, replacing the deficient endogenous enzyme and allowing normal carbohydrate absorption. The enzyme is derived from Saccharomyces cerevisiae and administered orally with each meal.
Mecanismo de Ação
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Perguntas frequentes
Sacrosidase is a liquid enzyme replacement therapy containing recombinant yeast sacrosidase (sucrase), used to treat congenital sucrase-isomaltase deficiency (CSID), a rare genetic disorder. It hydrolyzes dietary sucrose into fructose and glucose in the small intestinal brush border, replacing the deficient endogenous enzyme and allowing normal carbohydrate absorption. The enzyme is derived from Saccharomyces cerevisiae and administered orally with each meal.
As a recombinant protein, it replicates the function of the naturally occurring human protein, supplementing or replacing deficient endogenous production to restore normal physiological activity.
Yes, Sacrosidase is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201487. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="sacrosidase"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/sacrosidase/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/sacrosidase/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/sacrosidase/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="sacrosidase"></drugfyi-drug>